EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

THU624 Opioid Induced Adrenal Insufficiency (OIAI) Presenting With Altered Mental Status

Darya Bondarenko, Mobeen Ahmad, Glenn Alan McGrath

Journal of the Endocrine Society · 05.10.2023 · 7 (Supplement_1)

DOI: 10.1210/jendso/bvad114.154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 05.10.2023. Verfasst von Darya Bondarenko und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disclosure: D. Bondarenko: None. M. Ahmad: None. G.A. McGrath: None.

Background

Opioid suppression of the hypothalamic-pituitary-adrenal (HPA) axis via inhibition of corticotropin releasing hormone secretion leading to secondary adrenal insufficiency (AI) has been described in literature. Biochemical secondary AI is evident in 6-50% of patients on chronic opioids; fewer cases are reported presenting with clinical AI.1 We present a rare case of symptomatic opioid-induced AI (OIAI) with clinical improvement on initiation of hydrocortisone. Clinical Case: A 49-year-old female on daily buprenorphine (20 mg) and naltrexone (5 mg) presented to the hospital with syncope and hypotension (79/49 mmHg). AM cortisol was 6.2 mcg/dL, a cosyntropin stimulation test was performed, but there was technical difficulty with the results. She was started on midodrine 2.5 mg three times daily and referred to outpatient endocrinology for follow up. Weeks later, outpatient cosyntropin stimulation test showed baseline cortisol of 18 mcg/dL with increase to 26 mcg/dL. Simultaneous adrenocorticotrophic hormone (ACTH) was 16.9 pg/mL. AI was ruled out. Seven years later she presented with acute lethargy, confusion, and memory loss over several days. AM cortisol was 1.6 mcg/dL and cosyntropin stimulation test increased cortisol to 15.1 mcg/dL (normal response being 18 mcg/dL or greater). ACTH was 24 pg/mL. The abnormal cosyntropin stimulation test results are consistent with AI, and lack of elevation of morning ACTH is consistent with secondary AI.2 Hydrocortisone therapy was started and midodrine was held due to elevated blood pressure after initiation of steroids. She was discharged on hydrocortisone 15 mg each morning and 5 mg each afternoon. Within 10 days of initiation of glucocorticoid replacement therapy her neurologic symptoms improved and midodrine discontinued. Prescription Drug Monitoring Program (PDMP) review shows reduction of buprenorphine (16 mg) and naltrexone (4 mg).

Conclusion

Data on management of OIAI and recovery of the HPA axis with or without cessation of opioid therapy is limited. This case highlights that opioids should be considered as a potential cause of secondary AI. Further follow-up of this case and other OIAI cases would provide insight into management of opioid therapy, continuation of glucocorticoid therapy, and recovery of HPA axis. This data could provide basis for OIAI management recommendations. Reference: (1) Fountas, A., Prof, S.V.U., Karavitaki, N. Opioid-induced endocrinopathies. Lancet Diabetes Endocrinol. 2020;8(1);68-80. (2) Bornstein, S.R., Allolio, B., Arlt, W., et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocr. 2016;101(2);364-389. Presentation: Thursday, June 15, 2023

Zitieren

APA

Bondarenko, D., Ahmad, M., & McGrath, G. A. (2023). THU624 Opioid Induced Adrenal Insufficiency (OIAI) Presenting With Altered Mental Status. Journal of the Endocrine Society, 7(Supplement_1). https://doi.org/10.1210/jendso/bvad114.154

Vancouver

Bondarenko D, Ahmad M, McGrath GA. THU624 Opioid Induced Adrenal Insufficiency (OIAI) Presenting With Altered Mental Status. Journal of the Endocrine Society. 2023;7(Supplement_1). doi:10.1210/jendso/bvad114.154

BibTeX
@article{Bondarenko2023,
  author = {Bondarenko, Darya and Ahmad, Mobeen and McGrath, Glenn Alan},
  title = {THU624 Opioid Induced Adrenal Insufficiency (OIAI) Presenting With Altered Mental Status},
  journal = {Journal of the Endocrine Society},
  year = {2023},
  volume = {7},
  number = {Supplement_1},
  doi = {10.1210/jendso/bvad114.154}
}
Kostenlos starten →